Literature DB >> 15095801

Deep tendon reflexes, magnesium, and calcium: assessments and implications.

Jan M Nick1.   

Abstract

The perinatal nurse, in collaboration with physicians, can use deep tendon reflexes as a powerful tool in determining the need to start, adjust, or stop magnesium infusion. Toxicity can be detected using physical manifestations as a guide. Clinical signs may be a better indicator than serum levels of tissue levels of magnesium. Whether magnesium is given to prevent seizures or for tocolysis, patients in both situations are at risk for developing toxicity and must be assessed regularly to ensure patient safety.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095801     DOI: 10.1177/0884217504263145

Source DB:  PubMed          Journal:  J Obstet Gynecol Neonatal Nurs        ISSN: 0090-0311


  3 in total

1.  Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study.

Authors:  Tonya S Orchard; Joseph C Larson; Nora Alghothani; Sharon Bout-Tabaku; Jane A Cauley; Zhao Chen; Andrea Z LaCroix; Jean Wactawski-Wende; Rebecca D Jackson
Journal:  Am J Clin Nutr       Date:  2014-02-05       Impact factor: 7.045

2.  Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.

Authors:  Lihong Du; Larissa Wenning; Elizabeth Migoya; Yan Xu; Brendan Carvalho; Kathleen Brookfield; Han Witjes; Rik de Greef; Pisake Lumbiganon; Ussanee Sangkomkamhang; Vitaya Titapant; Lelia Duley; Qian Long; Olufemi T Oladapo
Journal:  J Clin Pharmacol       Date:  2018-11-13       Impact factor: 3.126

3.  Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure-Response Modeling and Simulation Study.

Authors:  Lihong Du; Larissa A Wenning; Brendan Carvalho; Lelia Duley; Kathleen F Brookfield; Han Witjes; Rik de Greef; Pisake Lumbiganon; Vitaya Titapant; Kiattisak Kongwattanakul; Qian Long; Ussanee S Sangkomkamhang; Ahmet M Gülmezoglu; Olufemi T Oladapo
Journal:  J Clin Pharmacol       Date:  2019-06-03       Impact factor: 3.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.